DUBLIN–(BUSINESS WIRE)–The “UK: CBD and Cannabis Regulation” report has been added to ResearchAndMarkets.com’s offering.
This report offers a comprehensive overview of the regulatory framework for hemp, CBD, and cannabis in the UK, covering everything from cultivation and processing to extracts and finished products, import/export, and the medical and recreational cannabis regimes.
Cannabis is a controlled Class B drug in the UK under the Misuse of Drugs (MDR) Act 1971 and Schedule 1 of Misuse of Drugs Regulations 2001. It is defined as any plant of the genus Cannabis or any part of the plant and it does not include seeds, mature stalks, and fibre made from mature stalks.
In the immediate future, the government could set a limit for THC levels in cannabinoid products at 50 micrograms per single serving, as recommended by the Advisory Council on the Misuse of Drugs (ACMD). The UK is also expected to finalize a transition towards a fully legal CBD-containing edibles market.
Key Topics Covered:
1 Executive Summary
2 Outlook
3 Hemp Plant
4 Extracts As Finished Products
5 Finished Products Containing CBD and Extracts
6 Import And Export Requirements
7 Minor Cannabinoids
8 Medical Cannabis
9 Recreational Cannabis
10 Relevant Laws
11 Relevant Bodies
For more information about this report visit https://www.researchandmarkets.com/r/9ijpgg
